ACAD
28.26
+0.62
+2.24%
AEMD
2.37
+0.22
+10.23%
APRI
1.1
+0.01
+0.92%
ARNA
16.53
+1.3
+8.54%
ATEC
1.83
+0.04
+2.23%
CNAT
5.6
+0.14
+2.56%
CRXM
0.175
0.00
0.00%
CYTX
1.13
-0.03
-2.59%
DXCM
75.28
+0.34
+0.45%
GNMK
12.51
+0.27
+2.21%
HALO
13.55
-0.44
-3.15%
ILMN
181
+4.64
+2.63%
INNV
0.115
+0.004
+3.604%
INO
8.23
+0.11
+1.35%
ISCO
1.143
-0.008
-0.6522%
ISIS
57.56
0.00
0.00%
LGND
121.37
+2.21
+1.85%
LPTN
2.93
-0.08
-2.66%
MBVX
1.44
0.00
0.00%
MEIP
2.44
+0.1
+4.27%
MNOV
5.28
+0.02
+0.38%
MRTX
3.65
-0.1
-2.67%
MSTX
0.131
-0.007
-5.278%
NBIX
46.77
+1.21
+2.66%
NUVA
78.03
+2.49
+3.30%
ONCS
1.24
+0.06
+5.08%
ONVO
2.69
+0.03
+1.13%
OREX
2.98
-0.1
-3.25%
OTIC
18.35
-0.1
-0.54%
QDEL
27.54
+0.38
+1.40%
RCPT
231.96
0.00
0.00%
RGLS
0.98
-0.07
-6.67%
RMD
77.17
+0.15
+0.19%
SCIE
0
0.00
-16.6667%
SPHS
2.39
-0.02
-0.83%
SRNE
2
-0.05
-2.44%
TROV
1.2
+0.13
+12.68%
VICL
2.6
+0.06
+2.36%
VOLC
18
0.00
0.00%
ZGNX
14.55
+0.25
+1.75%
ACAD
28.26
+0.62
+2.24%
AEMD
2.37
+0.22
+10.23%
APRI
1.1
+0.01
+0.92%
ARNA
16.53
+1.3
+8.54%
ATEC
1.83
+0.04
+2.23%
CNAT
5.6
+0.14
+2.56%
CRXM
0.175
0.00
0.00%
CYTX
1.13
-0.03
-2.59%
DXCM
75.28
+0.34
+0.45%
GNMK
12.51
+0.27
+2.21%
HALO
13.55
-0.44
-3.15%
ILMN
181
+4.64
+2.63%
INNV
0.115
+0.004
+3.604%
INO
8.23
+0.11
+1.35%
ISCO
1.143
-0.008
-0.6522%
ISIS
57.56
0.00
0.00%
LGND
121.37
+2.21
+1.85%
LPTN
2.93
-0.08
-2.66%
MBVX
1.44
0.00
0.00%
MEIP
2.44
+0.1
+4.27%
MNOV
5.28
+0.02
+0.38%
MRTX
3.65
-0.1
-2.67%
MSTX
0.131
-0.007
-5.278%
NBIX
46.77
+1.21
+2.66%
NUVA
78.03
+2.49
+3.30%
ONCS
1.24
+0.06
+5.08%
ONVO
2.69
+0.03
+1.13%
OREX
2.98
-0.1
-3.25%
OTIC
18.35
-0.1
-0.54%
QDEL
27.54
+0.38
+1.40%
RCPT
231.96
0.00
0.00%
RGLS
0.98
-0.07
-6.67%
RMD
77.17
+0.15
+0.19%
SCIE
0
0.00
-16.6667%
SPHS
2.39
-0.02
-0.83%
SRNE
2
-0.05
-2.44%
TROV
1.2
+0.13
+12.68%
VICL
2.6
+0.06
+2.36%
VOLC
18
0.00
0.00%
ZGNX
14.55
+0.25
+1.75%
Home » Archive by Category

Xconomy

Waving White Flag, Cerulean Merges With Dare Bio, Sells Cancer Drugs

March 20, 2017 – 6:41 am

Cerulean Pharma may have been able to survive one brush with death, but the second has proven fatal. Today, the Waltham, MA, company announced plans to merge with a privately held women’s health…

[[Click headline to continue reading.]]

With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work

March 17, 2017 – 4:55 am

Stung by slow sales of its next-generation anti-cholesterol drug, Amgen hopes new clinical data, released this morning, will spur doctors to boost prescriptions and—perhaps more…

[[Click headline to continue reading.]]

Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More

March 17, 2017 – 2:50 am

If it wasn’t clear that the Trump administration disdained most types of scientific inquiry and practice, the White House’s proposed budget drove the point home. The top-line figures: a…

[[Click headline to continue reading.]]

CRISPR Organs? eGenesis Raises $38M For Pig-To-Human Transplants

March 15, 2017 – 9:38 pm

One of the companies trying to revive the once-failed notion of xenotransplantation—transplanting animal organs or tissues into humans—has raised a significant round of cash. The $38…

[[Click headline to continue reading.]]

Human Longevity Offers Genome Sequencing Through MassMutual

March 14, 2017 – 9:00 pm

Human Longevity Inc., founded in 2014 by the gene pioneer J. Craig Venter to create a database for interpreting the human genome (and to make healthcare more proactive instead of reactive) said it…

[[Click headline to continue reading.]]

Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed?

March 13, 2017 – 1:35 am

It’s a struggle that comic-book fans know well. Ordinary people, bestowed with super powers from a spider bite or gamma rays, struggle to harness their own abilities. T cells, key soldiers of…

[[Click headline to continue reading.]]

Scott Gottlieb On Tap to Lead FDA, and Biopharma Exhales

March 10, 2017 – 1:05 pm

[Updated 3/12/17 with more comments, see below] The Trump administration has nominated Scott Gottlieb to be the new commissioner of the FDA, a selection that had the life sciences industry breathing…

[[Click headline to continue reading.]]

Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain Cancer

March 10, 2017 – 10:46 am

[Corrected 3/10/17, 3:27 pm. See below] Gene therapy developer Tocagen is preparing an initial public stock offering to finance clinical trials of its experimental treatment for a form of brain…

[[Click headline to continue reading.]]

Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More

March 10, 2017 – 4:36 am

We’ll start the roundup in Washington DC. The repeal of the Affordable Care Act, also known as Obamacare, began on the first day of the Trump administration. This week, the “replace”…

[[Click headline to continue reading.]]

Larry Smarr Drives Innovation as Experimental Patient of the Future

March 8, 2017 – 9:01 pm

In the years since he basically self-diagnosed his own Crohn’s Disease (before he had symptoms), Larry Smarr has served as a pioneer in the digital transformation of medicine and as an “n of 1”…

[[Click headline to continue reading.]]